Printer Friendly

Browse Multiple sclerosis topic

Development and progression subtopic


1-276 out of 276 article(s)
Title Author Type Date Words
Brain Molecule Helps Awaken Cells That Could Help Tackle MS. Sep 27, 2021 402
Epilepsia Partialis Continua in a Patient with Progressive Multiple Sclerosis/Progresif Multipl Sklerozlu Hastada Epilepsiya Parsiyalis Kontinua. Gorken, Gokhan; Yilgor, Abdullah Clinical report Jun 1, 2021 1679
Disease progression and therapy response vary in MS by ethnicity. Dotinga, Randy May 1, 2021 603
Roche reports further positive study results of Ocrevus. Apr 16, 2021 244
Genentech announces new Ocrevus analyses at AAN meeting. Apr 16, 2021 371
What Inflammasomes Tell Us About Multiple Sclerosis. Hocaoglu, Nisa; Gursoy, Azize Esra; Elibol, Birsen; Korkmaz, Nur Damla; Karakayali, Zehra Cemre; Ter Report Apr 1, 2021 375
Awareness of Saudi community toward multiple sclerosis in Qassim Region, Saudi Arabia. Hamdan, Nourah A. Al-; Otaibi, Eman A. Al-; Mutairi, Manal A. Al-; Mutairi, Malak G. Al-; Otaibi, Ol Jan 1, 2021 4427
Estimated Prevalence of Chronic Urinary Retention in Women in the United States. Connolly, Kevin M. Jan 1, 2021 4895
Immunotherapy For MS. Jan 1, 2021 422
Halting the damage: Study focuses on nerve cells. King, Mary E. Dec 22, 2020 1014
Assessment of IL-7RA T244I Polymorphism as a Risk Factor of Multiple Sclerosis in Turkish Population. Unsal, Mirac Aysen; Manukyan, Nuket Yildiz; Isik, Nihal; Saruhan Direskeneli, Guher Dec 1, 2020 2521
Role Of T Cells In MS. Dec 1, 2020 281
When MS isn't your only disease: Other chronic health conditions may be common--and connected. Uhland, Vicky Sep 22, 2020 1930
Balance and Gait Impairment in Persons with Multiple Sclerosis with the Absence of Clinical Disability/Klinik Yeti Yitimi Olmayan Multipl Sklerozlu Bireylerde Denge ve Yuruyus Bozuklugu. Ayan, Hatice; Ertekin, Ozge; Kahraman, Turhan; Ozakbas, Serkan Report Sep 1, 2020 4178
Compounds in Fruit Peels May Repair Neurons Damaged by MS. Jul 25, 2020 267
The Roles of Monocyte and Monocyte-Derived Macrophages in Common Brain Disorders. Zhao, Mingxia; Tuo, Houzhen; Wang, Shuhui; Zhao, Lin Jun 30, 2020 9125
Creative approaches: Barancik Prize winner Francisco J. Quintana's research targets progressive forms of MS. (solve). King, Mary E. Jun 22, 2020 1403
Magenta Therapeutics presents preclinical CD45-ADC data at EULAR meeting. Jun 5, 2020 431
A Descriptive Cross-Sectional Study of Manipulative Dexterity on Different Subtypes of Multiple Sclerosis. Huertas-Hoyas, Elisabet; Maximo-Bocanegra, Nuria; Diaz-Toro, Carlos; Montes-Diez, Raquel; Perez-Corr May 31, 2020 6153
Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development. Pegoretti, Valentina; Swanson, Kathryn A.; Bethea, John R.; Prober, Lesley; Eisel, Ulrich L.M.; Fisc May 31, 2020 15948
Gut check: An update on microbiome research in multiple sclerosis and an in-depth look at the work the iMSMS is doing. King, Mary E. Mar 22, 2020 1364
Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis. Zhou, Yang; Zhang, Xin; Xue, Hang; Liu, Lingling; Zhu, Jie; Jin, Tao Jan 1, 2020 8483
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection. Gudowska-Sawczuk, Monika; Mroczko, Barbara Dec 31, 2019 5574
Government of Alberta Supports Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis (CanProCo) with $1 Million Investment. Dec 10, 2019 1729
Magenta Therapeutics Presents First Immune Reset Results with Antibody-Drug Conjugate Across Multiple Autoimmune Diseases at ACR. Nov 13, 2019 445
Multiple Sclerosis Diagnosis and Management: A simple Literature Review. Alshammari, Yazeed Hamoud Mutlaq; Aldoghmi, Amjad Kamayan B.; Afif, Heba Sadiq A. Al; Alfayi, Banan Disease/Disorder overview Oct 1, 2019 3860
Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis. Bashamakh, Lujain F.; Alsharif, Shouq M.; Wayyani, Lamis A.; Alghamdi, Alaa E.; Fatani, Ghaida M.; A Survey Oct 1, 2019 3858
Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research. Snow, Nicholas J.; Wadden, Katie P.; Chaves, Arthur R.; Ploughman, Michelle Sep 30, 2019 17599
Genentech Presents New Six-year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis. Sep 18, 2019 241
Genentech (SIX: RO, ROG; OTCQX: RHHBY) - Genentech Presents New Six-Year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis -- 12/9/2019. Sep 17, 2019 789
Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis. Sep 13, 2019 482
An Investigation for Enhancing Registration Performance with Brain Atlas by Novel Image Inpainting Technique using Dice and Jaccard Score on Multiple Sclerosis (MS) Tissue. Faisal, Fahim; Nishat, Mirza Muntasir Sep 1, 2019 4741
Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents. Gavriilaki, Maria; Sakellari, Ioanna; Gavriilaki, Eleni; Kimiskidis, Vasilios K.; Anagnostopoulos, A Jul 31, 2019 7016
forward: A note from the President & CEO. Zagieboylo, Cyndi Jun 22, 2019 535
Monthly Pulse Methylprednisolone Therapy is Effective in Preventing Permanent Disease Progression in Secondary Progressive Multiple Sclerosis. Ozakbas, Serkan; Cinar, Bilge Piri; Oz, Didem; Kosehasanogullari, Gorkem; Kursun, Behice Bircan; Kah Clinical report Jun 1, 2019 3280
Exploring life history methodology in chronic illness: a study in Relapsing Remitting Multiple Sclerosis. Burke, Therese; Patching, Joanna Report Jun 1, 2019 4417
Clinical Features and Treatment in the Spectrum of Paroxysmal Dyskinesias: An Observational Study in South-West Castilla y Leon, Spain. Manso-Calderon, Raquel Report May 31, 2019 4304
Type 2 Inflammatory Responses in Autoimmune Demyelination of the Central Nervous System: Recent Advances. Costanza, Massimo May 31, 2019 8601
Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases. Vona, Rosa; Gambardella, Lucrezia; Cittadini, Camilla; Straface, Elisabetta; Pietraforte, Donatella May 31, 2019 15555
Genentech (SIX: RO, ROG; OTCQX: RHHBY) - Genentech to Present New OCREVUS (ocrelizumab) Data Analyses Showing Significant Reduction of Disability Progression in Relapsing and Primary Progressive Multiple Sclerosis at the AAN Annual Meeting -- 7/5/2019. May 14, 2019 667
Novel SNARE Complex Polymorphisms Associated with Multiple Sclerosis: Signs of Synaptopathy in Multiple Sclerosis. Yalin, Osman Ozgur; Edgunlu, Tuba Gokdogan; Celik, Sevim Karakas; Emre, Ufuk; Gunes, Taskin; Erdal, May 1, 2019 4171
Parry-Romberg Syndrome with Uhthoff's Phenomena: A Spectrum of Autoimmune Disease? Asanad, Samuel Apr 30, 2019 1866
Body mass index plays significant role in progression of multiple sclerosis: Study. Report Apr 15, 2019 663
Progressive Onset Multiple Sclerosis: Demographic, Clinical and Laboratory Characteristics of Patients With and Without Relapses in the Course. Kaymakamzade, Bahar; Kilic, Ahmet Kasim; Kurne, Asli Tuncer; Karabudak, Rana Report Mar 1, 2019 3816
"That Accident Really Set Off My MS!" Does Trauma Cause or Worsen Multiple Sclerosis? Hubbard, Jack E.; Hodge Jr., Samuel D., Jan 1, 2019 14923
A new phase: A diagnosis of secondary progressive MS can be scary, but there are strategies to help you live a full life. Uhland, Vicky Dec 22, 2018 3224
Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study. Qiu, Wei; Huang, De-Hui; Hou, Shi-Fang; Zhang, Mei-Ni; Jin, Tao; Dong, Hui-Qing; Peng, Hua; Zhang, C Report Dec 5, 2018 4795
The Assessment of Sexual Dysfunction in Male Patients with Multiple Sclerosis. Omer Odabas, Faruk; Gumus, Haluk; Akkurt, Halil Ekrem; Uca, Ali Ulvi; Yilmaz, Halim Report Dec 1, 2018 4599
Celgene says survey shows people with MS want more information on brain atrophy. Oct 11, 2018 381
Biogen seeks to improve outcomes for patients with MS. Oct 11, 2018 427
Genentech: Ocrevus data show early initiation of treatment reduces progression. Oct 10, 2018 306
Celebrating 10 Years Fighting MS. Sep 19, 2018 751
'Advancements in treatment providebetter quality of life for MS patients'. Sep 15, 2018 475
Multiple sclerosis programme caring for over 700 patients. Sep 12, 2018 506
HMC: New Advancements in MS Treatment Providing Enhanced Quality of Life for Patients. Sep 12, 2018 695
Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years/Multipl Skleroz Olgularinda Prognoz-Ozurluluk Biyoisaretcileri: Son Bes Yila Ait Literaturun Gozden Gecirilmesi. Kiylioglu, Nefati Sep 1, 2018 10267
Sociodemographic, environmental and lifestyle risk factors for multiple sclerosis development in the Western region of Saudi Arabia: A matched case control study. Halawani, Abdulrahman T.; Zeidan, Zeidan A.; Kareem, Abid M.; Alharthi, Areej A.; Almalki, Hani A. Report Aug 1, 2018 5402
forward: A note from the President & CEO. Zagieboylo, Cyndi Jun 22, 2018 366
Finding link between gut and brain. May 17, 2018 443
Genentech says 4 years of continuous Ocrevus treatment reduces RMS activity. Apr 23, 2018 243
Novartis reveals siponimod's efficacy on disability and cognition in secondary progressive MS patients. Apr 20, 2018 244
Novartis reveals siponimod's efficacy on disability and cognition in secondary progressive MS patients. Apr 20, 2018 240
Genentech Data Demonstrate Efficacy, Safety, and Benefits of Ocrevus in Relapsing and Primary Progressive MS. Apr 18, 2018 224
Multiple sclerosis and myasthenia gravis following severe weight loss. Alanazy, Mohammed H.; Alomar, Majed A.; Aljafen, Bandar N.; Muayqil, Taim A. Apr 1, 2018 2006
Siponimod Cuts Risk of Disability Progression in Multiple Sclerosis; Reduction in 3-month confirmed disability progression in secondary progressive multiple sclerosis. Mar 23, 2018 254
Variant of EOMES Associated with Increasing Risk in Chinese Patients with Relapsing-remitting Multiple Sclerosis. Chen, Sheng; Zhang, Juan; Liu, Qi-Bing; Zhuang, Jing-Cong; Wu, Lei; Xu, Yong-Feng; Li, Hong-Fu; Wu, Report Mar 18, 2018 3294
Comparison of Brain Atrophy, Cognition and Optical Coherence Tomography Results Between Multiple Sclerosis Patients and Healthy Controls. Yurtogullari, Sukran; Taskapilioglu, Ozlem; Ozturk, Burkay; Bilgic, Basar; Hakyemez, Bahattin; Turke Report Mar 1, 2018 5368
Prediction of Conversion from Clinically Isolated Syndrome to Multiple Sclerosis According to Baseline Characteristics: A Prospective Study. Cinar, Bilge Piri; Ozakbas, Serkan Report Mar 1, 2018 7335
Experimental Biology and Medicine Journal Publishes Article on Minimally Invasive Biomarkers for Multiple Sclerosis. Feb 20, 2018 200
Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives. Chu, Fengna; Shi, Mingchao; Lang, Yue; Shen, Donghui; Jin, Tao; Zhu, Jie; Cui, Li Jan 1, 2018 13143
More than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis. Takasaki, Teruaki; Hagihara, Kanako; Satoh, Ryosuke; Sugiura, Reiko Jan 1, 2018 8776
Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer's Disease. Tandon, Ankit; Singh, Sangh Jyoti; Chaturvedi, Rajnish Kumar Jan 1, 2018 26785
Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab. Holmey, Trygve; Torkildsen, Oivind; Zarnovicky, Svetozar Jan 1, 2018 1621
The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases. Dupont, Anne-Claire; Largeau, Berenger; Guilloteau, Denis; Ribeiro, Maria Joao Santiago; Arlicot, Ni Jan 1, 2018 11651
Repetitive Transcranial Magnetic Stimulation, Cognition, and Multiple Sclerosis: An Overview. Nasios, Grigorios; Messinis, Lambros; Dardiotis, Efthimios; Papathanasopoulos, Panagiotis Jan 1, 2018 6744
Prevalence of sea, seb, sec, sed, and tsst-1 genes of Staphylococcus aureus in nasal carriage and their association with multiple sclerosis. Pakbaz, Zahra; Sahraian, Mohammad Ali; Sabzi, Samira; Mahmoodi, Mahmood; Pourmand, Mohammad Reza Report Dec 1, 2017 3455
Common clinical features of pediatric multiple sclerosis in Pakistan - A report of 15 cases. Nov 30, 2017 1820
Gut bacteria linked to multiple sclerosis. Nov 19, 2017 236
Data Show Ocrevus Reduces Risk of Progression of MS by up to 25%. Oct 30, 2017 426
An evaluation of etiological and radiological profile of patients of non-compressive myelopathy in a neurological institute of Eastern India. Singh, Rohini; Prasun, Nikhil; Ahmad, Shamshad Report Oct 1, 2017 2849
THE FIRST HOSPITAL-BASED REGISTRY OF PATIENTS WITH MULTIPLE SCLEROSIS IN CROATIA. Kes, Vanja Basic; Lisak, Marijana; Jurasic, Miljenka; Zavoreo, Iris; Dimitrovic, Ana; Kobasic, Ivana Report Sep 1, 2017 4490
Strength training cuts progression of multiple sclerosis: Study. Aug 1, 2017 385
Caring for a patient with multiple sclerosis. Porten, Lauren; Carrucan-Wood, Louise Jul 1, 2017 2509
The good 'bugs': Gut bacteria may play a role in the development and progression of MS. King, Mary E. Jun 22, 2017 1602
Efficacy of different durations of intravenous methylprednisolone treatment in relapses of multiple sclerosis. Kulu, Ugur; Tiftikcioglu, Bedile Irem; Zorlu, Yasar; Cetiner, Mustafa; Sener, Ufuk; Tuna, Gamze; Kir Report Mar 1, 2017 4167
New MS treatment could stop the disease for at least five years. Feb 21, 2017 697
New MS treatment could stop the disease for at least five years. Feb 21, 2017 693
Siemens Healthineers partners with Biogen to develop new MRI tools for multiple sclerosis. Jan 18, 2017 251
Siemens Healthineers partners with Biogen to develop new MRI tools for multiple sclerosis. Jan 18, 2017 247
Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis. Makshakov, Gleb; Magonov, Evgeniy; Totolyan, Natalia; Nazarov, Vladimir; Lapin, Sergey; Mazing, Alex Jan 1, 2017 4690
pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity. Zorzella-Pezavento, Sofia Fernanda Gonsalves; Chiuso-Minicucci, Fernanda; Franca, Thais Graziela Don Jan 1, 2017 6409
Multiple Sclerosis Presenting with Facial Twitching (Myokymia and Hemifacial Spasms). Hertz, Risha; Espinosa, James; Lucerna, Alan; Stranges, Doug Clinical report Jan 1, 2017 1451
Dimethyl Fumarate Induces Glutathione Recycling by Upregulation of Glutathione Reductase. Hoffmann, Christina; Dietrich, Michael; Herrmann, Ann-Kathrin; Schacht, Teresa; Albrecht, Philipp; M Report Jan 1, 2017 3743
The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy. Adamczyk, Bozena; Wawrzyniak, Slawomir; Kasperczyk, Slawomir; Adamczyk-Sowa, Monika Jan 1, 2017 8941
Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches. Niedziela, Natalia; Adamczyk-Sowa, Monika; Niedziela, Jacek T.; Mazur, Bogdan; Kluczewska, Ewa; Sowa Report Jan 1, 2017 8736
Exciting field offers promises-and risks. King, Mary E. Dec 22, 2016 2710
Mum's PS54k drive for MS treatment. Nov 7, 2016 466
WCM-Q, HMC researchers win prestigious funding. Oct 19, 2016 510
It's natural to have concerns about pregnancy when you have MS, but most of what we know is good news. Patz, Aviva Sep 22, 2016 2564
Vitamin D: offers hope for multiple sclerosis. Rosick, Edward R. Sep 1, 2016 1987
MS sufferer in PS40,000 fundraising mission for pioneering treatment in Mexico; ALLISON, 50, BELIEVES NEW STEM CELL TREATMENT - NOT AVAILABLE ON NHS - WILL HALT HER CRIPPLING SYMPTOMS. Sep 1, 2016 438
A caring community helped Keith Johnson get back in his kayak. Johnson, Keith Personal account Jun 22, 2016 356
MS Breakthrough: Replacing Diseased Immune System Halts Progression, Allows Repair. Jun 11, 2016 1208
Psychosocial factors influencing lifestyle physical activity engagement of African Americans with multiple sclerosis: a qualitative study. Chiu, Chung-Yi; Bezyak, Jill; Griffith, Desiree; Motl, Robert Report Apr 1, 2016 4426
Barriers to and facilitators of employment among Americans with multiple sclerosis: results of a qualitative focus group study. Bogenschutz, Matthew; Rumrill, Phillip D., Jr.; Seward, Hannah E.; Inge, Katherine J.; Hinterlong, P Report Apr 1, 2016 9299
Telehealth is emerging as key way to manage MS and other chronic diseases. Salamon, Maureen Mar 22, 2016 1663
INNOVATIVE THERAPIES REDEFINE TREATMENT GOALS IN MULTIPLE SCLEROSIS. Lazibat, Ines; Samija, Radenka Kuzmanic; Rotim, Kresimir Report Mar 1, 2016 4380
New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis. Adamczyk, Bozena; Adamczyk-Sowa, Monika Disease/Disorder overview Jan 1, 2016 13491
Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases. Chiurchiu, Valerio; Orlacchio, Antonio; Maccarrone, Mauro Jan 1, 2016 10029
The elderly person with multiple sclerosis: clinical implications for the increasing life-span. Buhse, Marijean Report Dec 1, 2015 5112
Vitamin D and sunlight are not the same. Gaby, Alan R. Author abstract Nov 1, 2015 304
Learn to distinguish symptoms of progressing MS from normal aging--and from other health conditions. Patz, Aviva Report Sep 22, 2015 2769
Cardiovascular characteristics of SCI/D outpatients referred to a Kinesiotherapy wellness exercise program. Figoni, Stephen F.; Chen, Lily K. Report Sep 22, 2015 5945
Do thalidomides have a role in the treatment of multiple sclerosis? Sherbet, G.V. Sep 1, 2015 974
New research reveals that restful slumber eludes many with MS. Salamon, Maureen Jun 22, 2015 739
Even people with progressive MS can reap the benefits of exercise by working with specialists to develop home-based programs. Uhland, Vicky Jun 22, 2015 2701
Central post-stroke pain in stroke patients: incidence and the effect on quality of life. Kilic, Zeynep; Erhan, Belgin; Gunduz, Berrin; Iska Elvan, Gulsun Report Jun 1, 2015 4245
Mecanismos patogenicos en el desarrollo de la esclerosis multiple: ambiente, genes, sistema inmune y estres oxidativo. Flores-Alvarado, Luis Javier; Gabriel-Ortiz, Genaro; Pacheco-Moises, Fermin P.; Bitzer-Quintero, Osc Jun 1, 2015 6852
New target identified in fight against Alzheimer's, multiple sclerosis. Brief article May 1, 2015 181
Pets and service animals can make life with MS a bit easier--emotionally and physically. Uhland, Vicky Report Mar 22, 2015 1246
Google X, Biogen work the data in MS study. Chen, Caroline Jan 28, 2015 679
MS progression linked to whole brain atrophy. Moon, Mary Ann Apr 1, 2014 294
Cholesterol Lowering Drug Slows Progression of Advanced Multiple Sclerosis. Mar 19, 2014 454
Vitamin D could slow multiple sclerosis: study. Feb 17, 2014 372
Vitamin D could slow multiple sclerosis: study. Feb 5, 2014 373
Vitamin D could slow multiple sclerosis: study. Jan 22, 2014 393
Vitamin D Prevents Progression of Multiple Sclerosis. Jan 22, 2014 421
Sunlight can reduce multiple sclerosis progression. Jan 21, 2014 212
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis. Adli, Oussama El Yazami; Corcos, Jacques Report Jan 1, 2014 5902
Disease modifying therapy in multiple sclerosis. Williams, U.E.; Oparah, S.K.; Philip-Ephraim, E.E. Report Jan 1, 2014 5423
Spatial analysis of global prevalence of multiple sclerosis suggests need for an updated prevalence scale. Wade, Brett J. Report Jan 1, 2014 3533
The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis. Duffy, Samuel S.; Lees, Justin G.; Moalem-Taylor, Gila Report Jan 1, 2014 15298
The prevalence of familial multiple sclerosis in Saskatoon, Saskatchewan. Hader, Walter J.; Yee, Irene M. Report Jan 1, 2014 4901
Multiple sclerosis: evaluation of purine nucleotide metabolism in central nervous system in association with serum levels of selected fat-soluble antioxidants. Kuracka, L'ubomir; Kalnovicova, Terezia; Kucharska, Jarmila; Turcani, Peter Report Jan 1, 2014 6936
Serum leptin levels in treatment-naive patients with clinically isolated syndrome or relapsing-remitting multiple sclerosis. Evangelopoulos, Maria Eleftheria; Koutsis, Georgios; Markianos, Manolis Report Jan 1, 2014 4270
Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis. Bellavista, Elena; Santoro, Aurelia; Galimberti, Daniela; Comi, Cristoforo; Luciani, Fabio; Mishto, Report Jan 1, 2014 10718
Multiple sclerosis research: diagnostics, disease-modifying treatments, and emerging therapies. Costello, Kathleen Report Dec 1, 2013 7181
JK GIFT FOR MUM; MS research clinic funded with Harry Potter author's PS10m donation opens. Oct 9, 2013 358
Study: pot not too hot for MS. Brief article Oct 1, 2013 138
Objective and subjective measures reflect different aspects of balance in multiple sclerosis. Cameron, Michelle H.; Huisinga, Jessie Report Oct 1, 2013 5192
The serial unified multicenter MS investigation (SUMMIT) study is generating excitement in its quest to unravel the mystery of MS progression. Shryer, Donna Sep 22, 2013 1317
Karo Bio awarded USD0.5m in funding from the National MS Society to develop ERbeta agonists treatment for progressive MS. Sep 12, 2013 194
Karo Bio awarded USD0.5m in funding from the National MS Society to develop ERbeta agonists treatment for progressive MS. Sep 12, 2013 195
Higher vitamin D levels associated with fewer MS symptoms. Dye, D. Brief article Jan 1, 2013 193
Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis. Ramroodi, Nourollah; Sanadgol, Nima; Ganjali, Zohre; Niazi, Abbas Ali; Sarabandi, Vida; Moghtaderi, Report Jan 1, 2013 6172
Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis. Greer, Judith M. Jan 1, 2013 13607
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis. Healy, Brian C.; Engler, David; Glanz, Bonnie; Musallam, Alexander; Chitnis, Tanuja Report Jan 1, 2013 4939
Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis. Buc, Milan Report Jan 1, 2013 9026
Notch signaling and T-helper cells in EAE/MS. Bassil, Ribal; Orent, William; Elyaman, Wassim Report Jan 1, 2013 5392
Immunology and oxidative stress in multiple sclerosis: clinical and basic approach. Ortiz, Genaro G.; Pacheco-Moises, Fermin P.; Bitzer-Quintero, Oscar K.; Ramirez-Anguiano, Ana C.; Fl Jan 1, 2013 11722
La esclerosis multiple en el embarazo: reporte de tres casos en el Hospital Universitario de San Ignacio (HUSI). Toro C., Angelica Maria Report Jan 1, 2013 3680
Eyes could help detect multiple sclerosis' progression rate. Dec 30, 2012 254
FDA approves new oral therapy for MS. Dec 22, 2012 132
Does a virus help trigger MS? Bernstein, Sara Dec 22, 2012 1321
NIH-funded researchers show possible trigger for MS nerve damage. Brief article Nov 27, 2012 108
Research breakthrough selectively represses the immune system. Brief article Nov 19, 2012 115
Multiple sclerosis: environmental factors and treatments--Part 1. Marchese, Marianne Report Nov 1, 2012 2771
New multiple sclerosis treatment reduces relapses by about 50 percent. Nov 1, 2012 117
Dimethyl fumarate cut MS relapses, lesions. Otto, M. Alexander Nov 1, 2012 442
THC failed to delay progression of multiple sclerosis. Nov 1, 2012 545
NIH researchers implicate unique cell type in multiple sclerosis. Brief article Aug 1, 2012 121
Dimethyl fumarate cut relapse rates in MS. Otto, M. Alexander Jul 1, 2012 508
Marijuana's THC didn't delay progression of multiple sclerosis. Jul 1, 2012 414
Active cannabis ingredient doesn't slow progression of multiple sclerosis. Jun 16, 2012 655
Multiple Sclerosis: the disease of a thousand faces. May 31, 2012 471
Cannabis 'does not slow progression' of multiple sclerosis. May 30, 2012 194
IBM Analytics used by researchers at SUNY to improve patient cares in Multiple Sclerosis. Apr 27, 2012 275
Endosymbiotic actinidic archaea and viroids-role in immune regulation. Ravikumar, Kurup A.; Kurup, Parameswara Achutha Report Mar 31, 2012 3288
Angioplasty may help ease symptoms of multiple sclerosis. Mar 26, 2012 658
Exercise: 'Friend or Foe' for people with multiple sclerosis who experience fatigue? Smith, Catherine Report Mar 1, 2012 3489
New studies. Brief article Feb 1, 2012 223
A cholesterol and actinide dependent shadow biosphere of archaea and viroids in autoimmune diseases. Kurup A., Ravikumar; Kurup, Parameswara Achutha Report Dec 31, 2011 4090
Friendly bacteria may initiate MS: gut microbes appear to set off immune response in mice. Saey, Tina Hesman Dec 3, 2011 322
Disease-modifying agents in progressive multiple sclerosis: management of 100 patients at Louis Stokes Cleveland VAMC, spinal cord injury division. Mangla, Saisho; Jain, Seema; Selkirk, Stephen Report Oct 1, 2011 4528
Unlocking the puzzle of progression: the puzzle is big and full of missing pieces. Today, teams of researchers around the planet are combining their efforts to change that. O'Dell, Holly Cover story May 24, 2011 2785
Oral laquinimod reduced MS relapses by 23%. Boschert, Sherry May 15, 2011 554
New MS criteria aim to simplify diagnosis: changes to McDonald criteria should speed diagnosis and reduce MRI examinations. Wachter, Kerri Apr 15, 2011 1115
Novartis Gilenya lowers risk of MS disability progression. Apr 11, 2011 243
Clinical measurement of limb spasticity in adults: state of the science. Bhimani, Rozina H.; Anderson, Lisa C.; Henly, Susan J.; Stoddard, Sarah A. Disease/Disorder overview Apr 1, 2011 7341
Peripheral blood monocytes in multiple sclerosis exacerbations. Clinical report Mar 31, 2011 2158
Tackling the mystery of MS progression. Bernstein, Sara Mar 17, 2011 1141
How sunlight may reduce the severity of multiple sclerosis. Mar 14, 2011 500
Emerging oral therapies for multiple sclerosis. Miller, Colleen E.; Umhauer, Margaret A. Report Feb 1, 2011 7701
Fingolimod (Gilenya): how far will it go to treat MS? Drug overview Dec 22, 2010 1213
Propelling MS research through tough times. O'Looney, Patricia Dec 22, 2010 949
Multiple sclerosis. Disease/Disorder overview Dec 1, 2010 6077
MS disease activity shows seasonal variation. Evans, Jeff Dec 1, 2010 524
Impact of earthquake on multiple sclerosis attacks/Depremin multipl skleroz ataklarina etkisi. Tuzun, Erdem; Polat, Aslihan; Akman-Demir, Gulsen; Kurtuncu, Murat; Mutlu, Melike; Aksay, Bahar; Bil Report Dec 1, 2010 2829
Relation of serum uric acid level with cognitive functions and number of plaques in patients with relapsing-remitting multiple sclerosis/Relapsing-remitting multipl skleroz hastalarinda serum urik asit duzeyinin kognitif fonksiyonlar ve plak sayisi ile iliskisi. Yoldas, Tahir Kurtulus; Keklikoglu, Hava Donmez; Zengin, Ozkan; Solak, Elif Banu; Keskin, Selda Report Dec 1, 2010 3404
Recent developments in the early diagnosis and management of multiple sclerosis. Ross, Amy Perrin; Thrower, Ben W. Report Dec 1, 2010 8621
Early treatment slowed progression of MS. Worcester, Sharon Clinical report Nov 15, 2010 565
Teriflunomide reduced MS relapse rate by 31%. Worcester, Sharon Nov 1, 2010 760
Teriflunomide lowers annualized relapse rate 30% in MS. Worcester, Sharon Nov 1, 2010 532
The turbid crystal ball: life plans affected by MS: literature and patient narrative compared. Das, T.; Kaptein, A.A.; Haan, J. Clinical report Nov 1, 2010 2598
Cutaneous side-effects of immunomodulators in MS. Lebrun, C.; Bertagna, M.; Cohen, M. Clinical report Nov 1, 2010 3656
Multiple Sclerosis: The Big Questions--the MS Forum Workshop. Goodin, D.S. Conference notes Nov 1, 2010 4412
Illness onset as status passage for people with multiple sclerosis (MS). Vickers, Margaret H. Report Sep 22, 2010 8979
Acute psychosis as the initial presentation of MS: a case report. Aggarwal, A.; Sharma, D.D.; Kumar, R.; Sharma, R.C. Clinical report Jul 1, 2010 1809
Epstein-Barr virus and MS: causality or association? Ludwin, S.K.; Jacobson, S. Clinical report Jul 1, 2010 3853
The clinical usefulness of routine MRI assessment. Arnold, D.L.; Stone, L. Clinical report Jul 1, 2010 3168
Multiple sclerosis (MS) is a chronic, sometimes disabling, disease of the central nervous system. Disease/Disorder overview Jun 1, 2010 1128
Genes don't tell whole story of MS: twin study points to a still unknown environmental trigger. Saey, Tina Hesman May 22, 2010 576
Statins 'slow multiple sclerosis progression'. Apr 15, 2010 414
Novartis presents results on multiple sclerosis therapy Gilenia. Apr 13, 2010 303
VALT reaches out to veterans. Durand, Marcella Mar 22, 2010 386
Investigating ion channels for MS symptoms, and even neuroprotection. Bernstein, Sara Mar 22, 2010 1271
Glimmers of hope for people with progressive MS. Richert, John R. Report Mar 22, 2010 836
Treatment offering hope to MS sufferer. Mar 15, 2010 422
Diagnosing depression in MS in the face of overlapping symptoms. Patten, S.B. Report Mar 1, 2010 2001
Utility of routine neuropsychological assessment for early identification of cognitive impairment in MS. Hoogs, M.; Morrow, S.; Benedict, R.H.B. Report Mar 1, 2010 4425
Cyclophosphamide Treatment of MS: current therapeutic approaches and treatment regimens. Elkhalifa, A.S.; Weiner, H.L. Report Mar 1, 2010 4786
Clinical usefulness of cerebrospinal fluid evaluation. Fredrikson, S. Report Mar 1, 2010 2299
Managing fatigue: clinical correlates, assessment procedures and therapeutic strategies. Penner, I.K.; Calabrese, P. Report Mar 1, 2010 4326
Oral agents for multiple sclerosis prove effective: discontinuation rates were low, but adverse event rates ranged from 8% to 14%. Moon, Mary Ann Feb 15, 2010 1035
Psychosocial experiences and perceptions of African Americans with multiple sclerosis: a pilot study. Chakravorty, Bonnie; Buchanan, Robert J.; Johnson, Owen; Tyry, Tuula; Vollmer, Timothy Report Jan 1, 2010 5755
Giving birth 'can slow multiple sclerosis progression'. Nov 24, 2009 427
Acute amnesia in MS revisited. Larner, A.J.; Young, C.A. Report Nov 1, 2009 1369
DRUG HOPE ON MS. Aug 18, 2009 90
MS smoke alert. Jul 20, 2009 147
Smoking linked to more rapid progression of multiple sclerosis. Jul 14, 2009 439
MS: is it one disease? Esiri, M.M. Report Jul 1, 2009 1816
Magnetic resonance findings in leucodystrophies and MS. Labauge, P. Report Jul 1, 2009 5715
MS: Is it one disease? Barnett, M.H.; Parratt, J.D.E.; Pollard, J.D.; Prineas, J.W. Report Jul 1, 2009 5146
MS Forum workshop: looking ahead--advances in multiple sclerosis in the next decade: Athens, Greece, 22 October 2008. Clanet, M.; Ebers, G.C Conference news Jul 1, 2009 1866
SPMS option? Jun 1, 2009 413
City heads MS study. Apr 21, 2009 230
Easing into the right seat. Blose, Chris Mar 22, 2009 959
Epstein-Barr virus seems to play role in multiple sclerosis progression. Mar 3, 2009 401
Th17 cells in MS and experimental autoimmune encephalomyelitis. Hofstetter, H.H.; Gold, R.; Hartung, H.-P. Report Mar 1, 2009 4714
Plasticity in MS: from functional imaging to rehabilitation. Pelletier, J.; Audoin, B.; Reuter, F.; Ranjeva, J.P. Report Mar 1, 2009 3351
Treat multiple sclerosis early to boost outcomes. Zoler, Mitchel L. Report Nov 15, 2008 986
Making college work for you. Wadsley, Patricia Sep 22, 2008 840
Consumer alert: two new devices for foot drop. Durand, Marcella Sep 22, 2008 1110
MS activists fight Medicare's 24-month waiting period. Sep 22, 2008 751
Fresh facts on the impact of mobility problems. Sep 22, 2008 325
Joint conference on primary-progressive MS focuses on unmet needs. Schneider, Diana M. Sep 22, 2008 972
Maintaining bone health. Nowack, Denise Jun 22, 2008 543
Giving back. King, Martha Jun 22, 2008 534
MS vs. good sex. King, Martha Brief article Jun 22, 2008 304
Real-life sex with MS. Wadsley, Patricia Jun 22, 2008 974
Rethinking sex. Durand, Marcella Jun 22, 2008 700
The legal reality: Meredith on the job. Russon, Helen M. Jun 22, 2008 966
Off to college--with MS. Bryant, Carrie Jun 22, 2008 648
Comparative studies of glatiramer acetate and interferon beta. Goodin, D. Jun 1, 2008 2357
Recurrent monofocal demyelinating disease. Jung, P.; Strittmatter, M.; Steinmetz, H. Clinical report Jun 1, 2008 2615
Role of optic neuritis diagnosis in the early identification and treatment of MS. Milonas, I.; Georgiadis, N. Report Jun 1, 2008 8983
Cure for MS 'in 10 years'. Apr 24, 2008 207
City team works to help MS patients; Research in little-explored area is hailed. Apr 16, 2008 604
Preparing for a colonoscopy. Schwarz, Shelley Peterman Mar 22, 2008 601
New hope for SSDI applicants. Mar 22, 2008 344
What causes MS? Looking for answers in people who have it. Bernstein, Sara Mar 22, 2008 2041
MS in Latin America. Luetic, G. Report Mar 1, 2008 3379
New lead in fight to treat MS. Dec 11, 2007 236
MS treatment plus antibiotic 'could slow down disease'. Clinical report Dec 11, 2007 358
'Expensive' drug does help MS, say doctors. Aug 3, 2007 351
Investigation of a cluster of multiple sclerosis in two elementary school cohorts. Garabedian, Matthew Author abstract Jun 1, 2007 4212
Prevalence of multiple sclerosis in 19 Texas Counties, 1998-2000. Wagner, Laurie Clinical report Jun 1, 2007 3291
Supplements, diet may stall advance of MS. Schneider, Mary Ellen Feb 15, 2007 636
The importance of the physical activity for obese carriers of multiple sclerosis/A importancia da atividade fisica para portadores de esclerose multipla obesos. Porto, Rafael de Melo; Raso, Vagner Jan 1, 2007 5222
Betaseron. Mechcatie, Elizabeth Dec 1, 2006 455
Why Me? Why Now? Why Multiple Sclerosis?: Making Meaning and Perceived Quality of Life in a Midwestern Sample of Patients With Multiple Sclerosis. Russell, Candyce S.; White, Mark B.; White, Carmel Parker Mar 22, 2006 9202
Oligodendrocyte cell death in pathogenesis of multiple sclerosis: protection of oligodendrocytes from apoptosis by complement. Cudrici, Cornelia Brief article Jan 1, 2006 102
Responsiveness of choice reaction and movement time in multiple sclerosis. Apache, R.R. Goyakla; Jackson, Deborah; Mattson, David H. Clinical report Jun 22, 2005 3868
Optic neuritis not likely to progress to MS: prognostic value of MRI. Finn, Robert Brief Article Jan 15, 2004 172
Can researchers stop MS progression? (Part 2). Dec 1, 2003 701
MS progression: can we stop it? (Part 1). Nov 1, 2003 1168
Myelin fat storage of envirnomental radon daughters in the etiology of multiple sclerosis--a new appoach. Lykken, Glenn I.; Momcilovic, Berislav Report Mar 1, 2003 456
Cellular treatments for multiple sclerosis. (Horizons). Brief Article Jun 1, 2002 225
New mothers with MS wanted for infant feeding study. Mar 22, 2000 158
Multiple Sclerosis in Pregnancy. Dec 22, 1998 145
A Case of Rapid Deterioration: Acute Multiple Sclerosis of the Marburg Type. Jasperson, Jan; Jones, Anne G. Dec 1, 1998 3226
Gadolinium: highlighting MRI: key to revelation? Shaw, Phyllis Jun 22, 1990 838
The ups and downs of multiple sclerosis. Fackelmann, K.A. Apr 22, 1989 587

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |